Age 18 years or older Positive RT PCR test for COVID-19 Full consent and acceptance of the patient or his companion for taking the drug Patient traceability Women should not become pregnant for 30 days after the end of the study patients should not take levamisole for five days before entering the study (because the half-life of ‎the drug is 16 hours)

Age 18 years or older Positive RT PCR test for COVID-19 Full consent and acceptance of the patient or his companion for taking the drug Patient traceability Women should not become pregnant for 30 days after the end of the study patients should not take levamisole for five days before entering the study (because the half-life of ‎the drug is 16 hours)